TONO-PEN AVIA Applanation Tonometer

Products	TONO-PEN AVIA Applanation Tonometer
Company	Reichert, Inc.
Item	TONO-PEN AVIA Applanation Tonometer
Features	Accurate and Easy to Use The TONO-PEN AVIA is designed to help eliminate operator error and functions in any position, making it ideal to use on all your patients, including those in beds or wheelchairs. Activated by the push of a button, the IOP measurement is displayed on two large, easy-to-read, LCD screens. Patients will appreciate the quick and gentle measurement process. Intelligent The TONO-PEN AVIA utilizes micro strain gauge technology and a 1.0mm transducer tip. The device displays the average of 10 independent readings along with a statistical confidence indicator, ensuring accurate, repeatable, and reliable tonometry results. Versatile The TONO-PEN AVIA tonometer features the same proven accuracy as the clinically trusted TONO-PEN XL, but with a more ergonomic design, four times longer lasting battery, and larger LCD screens. The proven reliability of Reicherts applanation tonometers allows operators to take IOP measurements confidently anytime, anywhere, and in any position.
Description	The Reichert TONO-PEN AVIA tonometer is an easy-to-use, hand-held instrument that provides IOP readings that correlate strongly with Goldmann tonometry. TONO-PEN AVIA has a lightweight, ergonomic design and advanced electronic measurement technology that enables operators to take fast and accurate IOP measurements with minimal training. TONO-PEN AVIA is powered by a long-life TONO-PEN AVIA POWERCEL battery pack, good for over 2,500 measurements. TONO-PEN AVIA, like the TONO-PEN XL, uses sanitized OCU-FILM tip covers to minimize the risk of patient cross contamination.
Info	Reichert, Inc. Customer Service: 716-686-4500 Web site: http://www.reichert.com/

TAG: TONO PEN AVIA Applanation Tonometer

...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...

Medicine Products:

Formate Fly Larvae (Maggot)Fluoxetine/Norfluoxetine Folate & Vitamin B12

(Date:10/10/2008)... BEDFORD, Mass., Oct. 10 /PRNewswire-FirstCall/...loper, manufacturer and supplier of premium,diagno...ts dedicated to,serving the healthcare needs of wo...uarter and fiscal 2008 operating results on Tuesda...ction with the release, management will,host a con...

(Date:10/10/2008)... PARK CITY, Utah, Oct. 10 /PRNewswire/ -- NuVie... management of Trace Life Sciences Inc.,(Trace), i...cyclotron,production facilities in Denton, Texas. ... Indium-111, Iodine-123 and Thallium-201 used in,m... NuView Chairman and,CEO, stated that "We are conf...

(Date:10/10/2008)... Coach Holly Warlick Teams Up with Legal and Me...rst-Ever Cancer and Careers Seminar in,Knoxville, ...gnition of National,Breast Cancer Awareness Month,... have joined forces with YWCA Knoxville, The Welln...ocate Holly Warlick, University of Tennessee,women...

(Date:10/10/2008)... The Healthcare Technolog...Care , Exton, PA (PRWEB) ...Valley Chapters of the national Healthcare Informa...ned forces to bring regional health information te...onal conference entitled The Healthcare Technology...

Breaking Medicine News(10 mins):Health News:Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 2 Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2 Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3 Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4 Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2

[0] Hologic, Inc. To Release Fourth Quarter and Fiscal 2008 Operating Results on Tuesday, November 11, 2008 [0] NuView Life Sciences Inc. Assumes Management of Trace Life Sciences Inc. Radioisotope Production Facility [0] Local Experts Help Women Living and Working with Cancer Even the Score [0] HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference

...ster that took place two decades ago, scientists h... not as harmful// as it is thought to be. This n...level of toleration or limit of radioactive exposu...sidered safe. This might stir up a debate over nuc...

...nt of $6 million for the Florida State University ...lexia in children.// The schedule involves unders.... The grant will fund the creation of a National ...linary Learning Disabilities Center at FSU. The ce...

...ve found that any kind of exercise will help to pr...Todd M. Manini, an exercise physiologist at the U....of reports out there saying that self-reported exe...ial. We wanted to see if just usual daily activity...

...ion called aortic dissection (a tear in the larges...//. His death brought the focus on this deadly dis... and genetic disorders. Now, researchers have publ... dissection, showing that 90 percent of patients w...

Other Medicine News:Health News:Research Fund for FSU to Eradicate Dyslexia 2 Health News:Physical Activity of any kind to Prolong Life 2 Health News:Aortic Dissection - A Deadly Condition 2 Health News:Aortic Dissection - A Deadly Condition 3 Health News:Aortic Dissection - A Deadly Condition 4

Overreacting to the effects of Radiation Research Fund for FSU to Eradicate Dyslexia Physical Activity of any kind to Prolong Life Aortic Dissection - A Deadly Condition

(Date:10/8/2008)...ay Someday Inform Treatments for Spinal Cord, Othe...ire-USNewswire/ -- A protein that enables,nerve ce...e in controlling,the developing nervous system. Re...ions to form among nerve cells may provide a basis...njuries to their nervous system,including spinal ...

(Date:10/8/2008)... program to evaluate TAXUS(R) Element(TM) Platinum...NATICK, Mass., Oct. 8 /- Bo...nounced that it has completed enrollment in,the PE...ird-generation,TAXUS(R) Element(TM) paclitaxel-elu...has enrolled nearly 1,500 patients at 100 U.S. and...

(Date:10/7/2008)...ct. 7 /- Prometheus Laboratories Inc....ced findings from its,development of PROMETHEUS(R)... irritable bowel syndrome (IBS). The findings sugg...rticular biomarkers in blood samples,between IBS a...iomarkers,combined with a proprietary algorithm, ...

(Date:10/7/2008)...LEXX Trial Presented at the Osteoarthritis Researc...RSIPPANY, N.J., Oct. 7 /- Ferring Pha...the FLEXX Trial of Osteoarthritis of the,Knee, sho...ighly pure,non-avian high molecular weight form of...ior to intra-articular saline (IA-saline) for the ...

Breaking Medicine Technology:Protein Shown to Play a Key Role in Normal Development of Nervous System 2 Protein Shown to Play a Key Role in Normal Development of Nervous System 3 Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 2 Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 3 Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent 4 Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2 Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3 Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2 Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3 Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4 Specific antagonism lowers blood pressure 63 1 New prion protein discovered by Canadian scientists may offer insight into mad cow disease 58 1 New prion protein discovered by Canadian scientists may offer insight into mad cow disease 58 2 Preclinical study suggests organ transplant drug may aid in lupus fight 53 1 Preclinical study suggests organ transplant drug may aid in lupus fight 53 2 First biomarker discovered that predicts prostate cancer outcome 48 1 First biomarker discovered that predicts prostate cancer outcome 48 2 First biomarker discovered that predicts prostate cancer outcome 48 3 First biomarker discovered that predicts prostate cancer outcome 48 4

[0] Protein Shown to Play a Key Role in Normal Development of Nervous System [0] Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent [0] Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting [1] Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period

...WIRE)--Jun 1, 2007 - OXiGENE, Inc.,(NASDAQ: OXGN, ...mpany developing novel therapeutics to treat cance...n of two abstracts in the,2007 Annual Meeting prog...ng of the American Society of Clinical Oncology (A...or the first time full data from a,randomized Phas...

... 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences ...se 2,monotherapy trial showing that tanespimycin d... patients with metastatic melanoma,including one ...d,prior chemotherapy (within 6 weeks of initiation...on-free survival for more than,six months and 20% ...

Other Medicine Technology:OXiGENE Abstracts Published in ASCO Program 2 OXiGENE Abstracts Published in ASCO Program 3 OXiGENE Abstracts Published in ASCO Program 4 Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 2 Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 3 Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO 4

OXiGENE Abstracts Published in ASCO Program Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity,of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO